Sirnaomics

Sirnaomics' mission is to advance RNAi technology with the proprietary positions on multi-targeted siRNA cocktail design and in vivo siRNA delivery for novel therapeutics. Sirnaomics, Inc. is dedicated to becoming the leader in the field of RNAi technology by spearheading into the targeted therapeutics market. Sirnaomics positions itself to addressing important market needs: the high demand for enhancing the efficacy of siRNA therapeutics, with potent multi-target design and efficient in vivo siRNA delivery. The company's partnership with big pharmas and major biotech companies, along with government funding and venture capital financing, will strengthen its financial resources to accelerate the development of the technology platforms and siRNA therapeutic products. Meanwhile, our strong ties with biopharmaceutical communities in Asia (China) give us great advantages to speed up the process of our pre-clinical and clinical studies for noval siRNA therapeutics.

Further Information: http://www.sirnaomics.com/index.html